they could easily announce they've sold out their latest funding block at any time. They have that Chinese conference coming up and who knows what else.
Wonder what announcing a $5 million capital raise would do to this stock's value?...
This is all before Phase II trials. If and when they get that far, the potential value of Prolanta really jumps, by the progress with the science if nothing else. They've reported that the capital they're looking to raise now is for Phase II trials which should be a pretty good indication that the current human trials are progressing well. (redman has said as much as well)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.